U.S., Sept. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07819435) titled 'Phase 2/3 Efficacy and Safety of PP405 in Adult Males With NHS Type IV/V' on Sept. 09.
Brief Summary: The study is designed to validate efficacy and long term safety of PP405.
Study Start Date: Sept., 2026
Study Type: INTERVENTIONAL
Condition:
Androgenetic Alopecia
Intervention:
DRUG: PP405 0.05% Topical Gel
Medicated topical gel containing PP405 0.05%
DRUG: Vehicle Topical Gel
Topical gel
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Pelage Pharmaceuticals, Inc.
Disclaimer: Curated by HT Syndication....